Rossi A - Search Results

1

Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD.

Price D, Yawn B, Brusselle G, Rossi A. Price D, et al. Among authors: rossi a. Prim Care Respir J. 2013 Mar;22(1):92-100. doi: 10.4104/pcrj.2012.00092. Prim Care Respir J. 2013. PMID: 23135217 Free PMC article. Review.

2

Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

Rossi AP, Zanardi E, Zamboni M, Rossi A. Rossi AP, et al. Among authors: rossi a. Drugs Aging. 2015 Sep;32(9):679-87. doi: 10.1007/s40266-015-0291-8. Drugs Aging. 2015. PMID: 26297533 Review.

3

How far is real life from COPD therapy guidelines? An Italian observational study.

Corrado A, Rossi A. Corrado A, et al. Among authors: rossi a. Respir Med. 2012 Jul;106(7):989-97. doi: 10.1016/j.rmed.2012.03.008. Epub 2012 Apr 5. Respir Med. 2012. PMID: 22483189 Free article. Clinical Trial.

4

Indacaterol therapy in patients with COPD not receiving other maintenance treatment.

Decramer M, Rossi A, Lawrence D, McBryan D. Decramer M, et al. Among authors: rossi a. Respir Med. 2012 Dec;106(12):1706-14. doi: 10.1016/j.rmed.2012.08.022. Epub 2012 Sep 29. Respir Med. 2012. PMID: 23031496 Free article. Review.

5

Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium.

Rossi A, Centanni S, Cerveri I, Gulotta C, Foresi A, Cazzola M, Brusasco V. Rossi A, et al. Respir Med. 2012 Jan;106(1):84-90. doi: 10.1016/j.rmed.2011.09.006. Epub 2011 Oct 27. Respir Med. 2012. PMID: 22035851 Free article. Clinical Trial.

6

Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety.

Rossi A, Khirani S, Cazzola M. Rossi A, et al. Int J Chron Obstruct Pulmon Dis. 2008;3(4):521-9. doi: 10.2147/copd.s1353. Int J Chron Obstruct Pulmon Dis. 2008. PMID: 19281071 Free PMC article. Review.

7

Clinical role of dual bronchodilation with an indacaterol-glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life.

Rossi A, Zanardi E, Poletti V, Cazzola M. Rossi A, et al. Int J Chron Obstruct Pulmon Dis. 2015 Jul 23;10:1383-92. doi: 10.2147/COPD.S55488. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26229457 Free PMC article. Review.

8

E pluribus plurima: multidimensional indices and clinical phenotypes in COPD.

Rossi A, Zanardi E. Rossi A, et al. Respir Res. 2011 Nov 14;12(1):152. doi: 10.1186/1465-9921-12-152. Respir Res. 2011. PMID: 22082092 Free PMC article. No abstract available.

9

The pathogenesis of COPD and IPF: distinct horns of the same devil?

Chilosi M, Poletti V, Rossi A. Chilosi M, et al. Among authors: rossi a. Respir Res. 2012 Jan 11;13(1):3. doi: 10.1186/1465-9921-13-3. Respir Res. 2012. PMID: 22235752 Free PMC article. Review.

10

Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial.

Rossi A, Inciardi RM, Rossi A, Temporelli PL, Lucci D, Gonzini L, Marchioli R, Nicolosi GL, Tavazzi L; GISSI-HF Investigators. Rossi A, et al. Pulm Pharmacol Ther. 2017 Jun;44:16-23. doi: 10.1016/j.pupt.2017.03.001. Epub 2017 Mar 3. Pulm Pharmacol Ther. 2017. PMID: 28263812 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,240 results

Search Page

Filters